Charlotte's Web Holdings (CWBHF) Change in Accured Expenses (2021 - 2026)

Charlotte's Web Holdings' (CWBHF) quarterly Change in Accured Expenses came in at -$537000.0 in Q1 2026, down 161.87% year-on-year from $868000.0 in Q1 2025, and up 83.79% on a QoQ basis from -$3.3 million in Q4 2025.

Charlotte's Web Holdings (CWBHF) Change in Accured Expenses (2021 - 2026) Analysis & Trends

Charlotte's Web Holdings (CWBHF) has 6 years of Change in Accured Expenses data on file, last reported at -$537000.0 in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 161.87% year-over-year to -$537000.0 in Q1 2026; TTM through Mar 2026 was -$2.5 million, a 163.48% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 million, down 129.24% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$537000.0, up from -$3.3 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CWBHF reached as high as $5.0 million in Q4 2024 and fell as low as -$3.6 million in Q4 2022.
  • Historically, Change in Accured Expenses has averaged -$83000.0 across 5 years, with a median of $33000.0 in 2025.
  • Across the five-year window, Change in Accured Expenses tumbled 344.32% in 2022 and surged 280.47% in 2024, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$3.6 million in 2022, then advanced by 22.7% to -$2.8 million in 2023, then jumped by 280.47% to $5.0 million in 2024, then tumbled by 166.37% to -$3.3 million in 2025, then surged by 83.79% to -$537000.0 in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$537000.0 in Q1 2026, -$3.3 million in Q4 2025, and $752000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.06 Bn 87.19 Bn - -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.51 Bn 30.57 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -
5 United Therapeutics 23.18 Bn 21.03 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 21.76 Bn 21.76 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn -
10 Charlotte's Web Holdings 41.51 Mn 36.32 Mn 5.20 Mn -537,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -537,000.00
Mar 31, 2026 -537,000.00
Dec 31, 2025 -3.31 Mn
Dec 31, 2025 -3.31 Mn
Sep 30, 2025 752,000.00
Sep 30, 2025 752,000.00
Jun 30, 2025 603,000.00
Jun 30, 2025 603,000.00
Mar 31, 2025 868,000.00
Mar 31, 2025 868,000.00
Dec 31, 2024 4.99 Mn
Dec 31, 2024 4.99 Mn
Sep 30, 2024 -980,000.00
Sep 30, 2024 -980,000.00
Jun 30, 2024 -949,000.00
Jun 30, 2024 -949,000.00
Mar 31, 2024 663,000.00
Mar 31, 2024 663,000.00
Dec 31, 2023 -2.77 Mn
Dec 31, 2023 -2.77 Mn